UK Healthcare Gazette
SEE OTHER BRANDS

Your healthcare and wellness news from the United Kingdom

UK Healthcare Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.

Press releases published on July 16, 2025

Influenza Treatment Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams

Influenza Treatment Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams

nfluenza is commonly known as flu and is a contagious respiratory infection, which is caused by influenza viruses. WILMINGTON, DE, UNITED STATES, July 16, 2025 /⁨EINPresswire.com⁩/ -- The global Influenza Treatment Market is expected to witness …

Healthcare Facility Management Market Forecast To 2031 - For Business Leaders, Analysts, And Strategic Teams

Healthcare Facility Management Market Forecast To 2031 - For Business Leaders, Analysts, And Strategic Teams

The launch of various healthcare facilities providing programs by private and public sector fuel the growth of the market. WILMINGTON, DE, UNITED STATES, July 16, 2025 /⁨EINPresswire.com⁩/ -- Healthcare facility management is the process of ensuring that …

Pitcher Positioned as the Leader in the SPARK Matrix™: Revenue Enablement Platform (REP), 2025 by QKS Group

Pitcher Positioned as the Leader in the SPARK Matrix™: Revenue Enablement Platform (REP), 2025 by QKS Group

Pitcher's comprehensive Revenue Enablement Platform technology has received strong ratings across the parameters of technology excellence and customer impact DENVER, MN, UNITED STATES, July 16, 2025 /⁨EINPresswire.com⁩/ -- QKS Group has named Pitcher as a …

Penta Security Wins Frost & Sullivan '2025 Frost & Sullivan’s Company of the Year Recognition'

Penta Security Wins Frost & Sullivan '2025 Frost & Sullivan’s Company of the Year Recognition'

SEOUL, SOUTH KOREA, July 16, 2025 /⁨EINPresswire.com⁩/ -- Leading cybersecurity company Penta Security has been honored with the “The South Korea Web Application Firewall Industry” award by global market research and consulting firm Frost …

Circle Cardiovascular Imaging Unveils Advanced Plaque  for the Analysis of Coronary Artery Disease

Circle Cardiovascular Imaging Unveils Advanced Plaque for the Analysis of Coronary Artery Disease

Empowering Hospitals with Direct Access to Innovation and Reimbursement MONTREAL, QUEBEC, CANADA, July 16, 2025 /⁨EINPresswire.com⁩/ -- Circle Cardiovascular Imaging (Circle CVI), a global leader in cardiovascular advanced post-processing imaging, …

Cancellation of NIDA’s free cannabis program at the University of Mississippi threatens termination of clinical trials

Cancellation of NIDA’s free cannabis program at the University of Mississippi threatens termination of clinical trials

Researchers will have to find alternative sources of cGMP cannabis from other DEA Manufacturers BRUNSWICK, ME, UNITED STATES, July 16, 2025 /⁨EINPresswire.com⁩/ -- Cancellation of the University of Mississippi’s “Production of Cannabis and Related …

OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain

OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain

After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in neuropathic corneal pain (NCP), as measured by Visual Analogue Scale (VAS), demonstrating highly effective treatment. Urcosimod (0.05%) …

Evox Therapeutics Expands Scientific Advisory Board

Evox Therapeutics Expands Scientific Advisory Board

OXFORD, United Kingdom, July 16, 2025 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (“Evox” or the “Company”), a biotechnology company developing innovative therapies for rare, genetically driven neurodegenerative diseases using a next-generation gene editing …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions